Retia Medical

Retia Medical celebrated summer and our summer interns this week with a little #IceCreamSocial. Every year we love it when our interns come in with their energy, curiosity, and enthusiasm. We enjoy teaching the next generation of engineers and always end up learning a few things ourselves! Total win-win. #summerinterns #startups #medicaldevice

As we celebrate Independence Day, we want to take a moment to express our pride in being an American company. At Retia Medical, we are committed to excellence and innovation, and we are proud that our products are made right here in the USA. Wishing everyone a safe and joyful 4th of July! #FourthOfJuly #IndependenceDay #MadeInUSA #ProudlyAmerican #RetiaMedical

📣 We are thrilled to announce the findings of a recent study that evaluated the accuracy of our Argos multi-beat analysis against the PiCCO pulse-contour analysis during a passive leg raise (PLR) and/or a fluid challenge (FC). 📣 In this study Dr. Bitker's group found that the Argos monitor has an excellent trending ability for cardiac output monitoring compared to the PiCCO thermodilution method, with a concordance of 90%. In 29 MICU patients with sepsis and septic shock, the Argos monitor was able to predict fluid responsiveness when undergoing a passive leg raise. Likewise, the Argos monitor correctly tracked fluid responders on receiving a fluid challenge. The article concludes that "the device [Argos] showed excellent diagnostic and predictive performance to predict preload dependence in a medical ICU population receiving norepinephrine".   https://lnkd.in/eg9bmudW

👨⚕️Clinicians... you have the below patient admitted into your ICU.. are you confident all your new nurses are trained properly to handle the below situation??? Patient Profile: Age: 65-year-old male Medical History: Hypertension, Type 2 Diabetes Current Condition: Admitted to ICU with severe sepsis secondary to a urinary tract infection. The patient is exhibiting signs of septic shock, including hypotension, tachycardia, altered mental status, and elevated lactate levels. Initial Presentation: Blood Pressure: 80/50 mmHg Heart Rate: 120 beats per minute Respiratory Rate: 28 breaths per minute Temperature: 39°C (102.2°F) Lactate Level: 4.5 mmol/L Urine Output: 10 ml/hour Clinical Challenges: Hemodynamic Instability: Low blood pressure and high heart rate indicate poor perfusion and possible multi-organ dysfunction. Fluid Resuscitation: Determining the optimal volume of fluids to administer to improve blood pressure without causing fluid overload. Vasopressor Management: Deciding on the type and dosage of vasopressors to maintain adequate blood pressure and organ perfusion. 💪 How can the Argos Hemodynamic Monitor help you and your staff? 💪 ✅ Guiding Fluid Resuscitation: Accurate measurement of stroke volume (SV) and pulse pressure variation (PPV) helps in assessing the patient’s fluid responsiveness. ✅ Optimizing Vasopressor Therapy: Real-time tracking of systemic vascular resistance (SVR) helps in titrating vasopressor dosage to achieve target mean arterial pressure (MAP). ✅ Monitoring Organ Perfusion: Continuous monitoring of parameters such as cardiac output helps in assessing whether vital organs are receiving adequate blood flow. 💡 Clinical Outcome: With the help of the Argos Hemodynamic Monitor, the ICU team can make accurate, informed, data-driven decisions regarding fluid management and vasopressor therapy. That may lead to enhanced overall patient outcomes and a decreased likelihood of complications associated with septic shock. #ICU #AACN #NURSES #ARGOS

The demand for Intensive Care Unit (ICU) services frequently surpasses the available workforce, leading to significant challenges in patient care. The repercussions of these staffing shortages are profound: 🚫 Increased Patient-to-Nurse Ratios can lead to less individualized attention, delayed response times, and potential increases in medical errors. 🚫 Extended ICU stays can result in delayed procedures and slower patient recovery times, thereby prolonging ICU stays. 🚫 Research has shown that staffing shortages in ICUs are associated with increased mortality rates due to suboptimal monitoring and delayed interventions. 👉 How Can the Argos help???? 👈 💡 Advanced data analytics through our patented MBA algorithm can predict patient deterioration, aiding in proactive rather than reactive care. 💡 Alerts for abnormal hemodynamic parameters can ensure that clinicians are immediately informed of any changes in a patient's condition, reducing the likelihood of missed warning signs due to high patient-to-nurse ratios. 💡 The Argos is designed for quick and straightforward installation minimizing downtime and disruptions to ICU operations. Its plug-and-play design means that the system can be up and running within a minute, unlike some competitors that require complex and time-consuming installations. For more information or to schedule a free demo please reach us at Info@retiamedical.com Sales@retiamedical.com www.retiamedical.com

Shortages of essential medical supplies, equipment, medications, and advanced technologies impede timely diagnosis, treatment, and management of critically ill patients. That right there is creating healthcare disparities and system inefficiencies within the US and abroad. Made here in the USA and with no disposables to order, stock, or expire, our Argos hemodynamic monitor solves all these issues. Trust our monitor to provide you the most accurate hemodynamic parameters when you need it most. 🏥 Below is a picture of our recent install at an institution that made the conscious decision to part ways with unreliable monitors and disposables to ensure their patients across all ICU's and OR's have the care they need when they need it. 🏥 To inquire about our monitors please reach out to us at: Infor@retiamedical.com Sales@retiamedical.com

🎉 TGIF from Retia Medical! 🎉 Happy Friday, everyone! Before we all head into the weekend, we wanted to highlight our unsung hero of the week: the Argos Hemodynamic Monitor. This amazing piece of technology has been working tirelessly in the OR and ICU's around the world, ensuring accurate and reliable hemodynamic data to enhance patient care. Imagine if the Argos Monitor could speak: 🗣️ "Hey there, I’ve been working overtime this week, keeping an eye on those hemodynamic parameters and making sure everything is just right so clinicians get the data they need!!!" Our team is incredibly proud of the advancements we’ve made with the Argos Monitor, contributing to improved patient outcomes and setting new standards in hemodynamic monitoring. It's innovations like these that drive our mission forward. As we head into the weekend, let's take a moment to also appreciate the hard work and dedication that makes these achievements possible, our clinicians. Your dedication to improving patient care is what motivates us to bring our technology to places that do not have it. Happy Friday! 🎉 #HappyFriday #RetiaMedical #ArgosMonitor #HealthcareInnovation #TGIF #MedicalTechnology #FridayFun

We are proud to have our CEO and Co-Founder Marc Zemel present today and share Retia's start-up story, the steps that were necessary to develop our product, and where our product is currently being used. He'll also share a sneak-peak of the team's vision for the future of the company. Please follow the link to and listen to the conversation for free! https://lnkd.in/gygaEcFE

" 💪 Starting the week off strong with another large installation at a prestigious Texas hospital! 💪 Huge shoutout to our amazing team David Karr Rick Alberts for ensuring this facilities monitors are set up and the staff is trained this week on the best hemodynamic monitor out on the market. At the end of the day, it's all about advancing healthcare and making a positive impact where it matters most! #NewWeekNewGoals  #Texas #HealthcareInnovation #Hemodynamics #criticalcare #ACCN

This week marks a truly special milestone for Retia Medical – our 13th anniversary! It feels like just yesterday when our founders, Ramakrishna Mukkamala and Marc Zemel, embarked on this incredible journey with a vision to make accurate hemodynamic data accessible to improve outcomes for ALL high-risk surgical and critically ill patients. With the unwavering support from Michael Vlock, z''l, and Karen Pritzker, Retia Medical was brought to life. Thirteen years later, we are proud to see our mission realized in 55 hospitals across 14 countries and 5 continents. This incredible achievement is a testament to the dedication and passion of our entire team and community. In 2022, after many years of steadfast support from the Pritzker Vlock Capital Management, we were thrilled to welcome the considerable backing of FRESENIUS MEDICAL CARE VENTURES, LLC ,Red Cedar Ventures, and other strategic partners. Your belief in our mission fuels our passion and drives us forward every day. To our esteemed Board members: Al Wiegman, Kevin Rocco, George Solomon, and others from prestigious institutions, thank you for your sound guidance and unwavering support. A heartfelt thank you to our clinical advisors: Ashish K. Khanna MD,MS,FCCP,FCCM,FASA , Roger S. Mecca MD, Bernd Saugel, Andrew Shaw, Gebhard Wagener, Benjamin Kohl, @Tim Miller (Duke), Michael O'Connor (UChicago). Your expertise and guidance have been instrumental in our success. And most importantly, to our incredible past and present employees, consultants, and suppliers – you are the backbone of Retia Medical. Your dedication, hard work, and commitment made everything we do possible. We are deeply grateful for each and every one of you. Here's to the next chapter of innovation and impact. We're excited to continue this journey with all of you, making a difference in the lives of patients around the world. Thank you all for being part of our story. Jerry Korten,Jon Fish,Humberto Contreras,Harsha Agashe,Alexander Markovic,Dylan Agyemang,Brenda Tinta, Timothy Luddy, Jacob L., E. Claire Vinson, Austin Mayo, Cathy Wilkes,Rosemarie Woodstock, David Karr, Rick Alberts @Amy Chen, @Brian Nelson